Ikaria, Inc. (IKAR) Files $200M IPO

May 13, 2010 4:41 PM EDT
Get Alerts IKAR Hot Sheet
Trade IKAR Now!
Join SI Premium – FREE
Ikaria, Inc. (Nasdaq: IKAR) filed a registration statement with the U.S. Securities and Exchange Commission for an initial public offering of its common stock. The proposed maximum aggregate offering price is $200 million. The company plans to list on the NASDAQ Global Market under the symbol "IKAR."

The offering is being made through Goldman Sachs, Morgan Stanley, Credit Suisse, Lazard Capital Markets, Cowen & Co., and Wedbush PacGrow Life Sciences.

Ikaria is a fully-integrated biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the significant unmet medical needs of critically ill patients.

You May Also Be Interested In

Related Categories


Related Entities

Credit Suisse, Morgan Stanley, Lazard, Cowen & Co

Add Your Comment